Merck & Co (MRK)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

2000 GALLOPING HILL ROAD KENILWORTH, NJ 07033

Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. The Company's operations are principally managed on a products basis and consist of two business segments. The Pharmaceutical segment includes human health pharmaceutical products marketed either directly or through joint ventures. These products consist of therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. The Vaccines and Infectious Diseases segment includes human health vaccine products marketed either directly or through a joint venture. These products consist of preventative pediatric, adolescent and adult vaccines, primarily administered at physician offices. Infectious disease products consist of therapeutic agents for the treatment of infection sold primarily to drug wholesalers and retailers, hospitals and government agencies.

Data based on most recent fiscal year report
Market Cap147.365 Billion Shares Outstanding2.724 Billion Avg Volume16.384 Million
1-Yr BETA vs S&P TR Current Ratio1.33 Quick Ratio1.06
View SEC Filings from MRK instead.
Q3 2018 All Institutions Hedge Funds 1
To trade MRK now:
Filers who had this stock in their top 10: 139 19 (1.83%)
13F Filers holding this stock: 2006 173 (16.7%)
Aggregate 13F shares on 09/30/2018: 1.957 Billion 115.508 Million
Aggregate 13F shares on 06/30/2018: 1.958 Billion 108.605 Million
Percent change: -0.03% 6.36%
Funds creating new positions: 117 18
Funds Adding to an existing position: 736 58
Funds closing out their position: 62 17
Funds reducing their position: 878 68
Heat Map Ranking for 09/30/2018 114
Heat Map Ranking for 06/30/2018 38
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MRK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

612 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

612 Thousand total shares from 7 transactions

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Acquired or Disposed Shares Owned Following Transaction Direct/Indirect Ownership

PERLMUTTER ROGER M - Officer EXE V-P & PRES, MRL

2018-11-08 S 225,443 d 141,555 direct

PERLMUTTER ROGER M - Officer EXE V-P & PRES, MRL

2018-11-08 M 225,443 a 366,998 direct

PERLMUTTER ROGER M - Officer EXE V-P & PRES, MRL

2018-11-08 M 225,443 d 0 direct

GERBERDING JULIE L. - Officer EVP STRAT COMM, GL PUB POLICY

2018-11-07 S 36,218 d 46,263 direct

GERBERDING JULIE L. - Officer EVP STRAT COMM, GL PUB POLICY

2018-11-07 M 36,218 a 82,481 direct

GERBERDING JULIE L. - Officer EVP STRAT COMM, GL PUB POLICY

2018-11-07 M 36,218 d 18,111 direct

SCHECHTER ADAM H - Officer EVP & PRES-GLOBAL HUMAN HEALTH

2018-11-01 M 277,879 d 0 direct

SCHECHTER ADAM H - Officer EVP & PRES-GLOBAL HUMAN HEALTH

2018-11-01 M 277,879 a 277,879 direct

SCHECHTER ADAM H - Officer EVP & PRES-GLOBAL HUMAN HEALTH

2018-11-01 S 145,135 d 0 direct

SCHECHTER ADAM H - Officer EVP & PRES-GLOBAL HUMAN HEALTH

2018-11-01 S 132,744 d 145,135 direct

WATSON ASHLEY - Officer SVP CHIEF ETHICS & COM OFFICER

2018-10-31 M 5,706 d 11,412 direct

WATSON ASHLEY - Officer SVP CHIEF ETHICS & COM OFFICER

2018-10-31 M 23,220 a 32,990 direct

WATSON ASHLEY - Officer SVP CHIEF ETHICS & COM OFFICER

2018-10-31 M 5,706 a 56,806 direct

WATSON ASHLEY - Officer SVP CHIEF ETHICS & COM OFFICER

2018-10-31 M 23,220 d 0 direct

WATSON ASHLEY - Officer SVP CHIEF ETHICS & COM OFFICER

2018-10-31 M 18,110 d 9,055 direct

WATSON ASHLEY - Officer SVP CHIEF ETHICS & COM OFFICER

2018-10-31 M 18,110 a 51,100 direct

WATSON ASHLEY - Officer SVP CHIEF ETHICS & COM OFFICER

2018-10-31 S 47,036 d 9,770 direct

MIZELL STEVEN - Officer EVP, HUMAN RESOURCES

2018-10-30 A 13,723 a 13,723 direct

SCHOLEFIELD JAMES H - Officer EVP,CHIEF INFO&DIGITAL OFFICER

2018-10-30 A 34,308 a 34,308 direct

DELUCA RICHARD R. - Officer EVP&PRES, MERCK ANIMAL HEALTH

2018-10-30 M 25,467 a 82,135 direct

DELUCA RICHARD R. - Officer EVP&PRES, MERCK ANIMAL HEALTH

2018-10-30 M 25,467 d 0 direct

MIZELL STEVEN - Officer EVP, HUMAN RESOURCES

2018-10-30 A 51,252 a 51,252 direct

SCHOLEFIELD JAMES H - Officer EVP,CHIEF INFO&DIGITAL OFFICER

2018-10-30 A 47,456 a 47,456 direct

DELUCA RICHARD R. - Officer EVP&PRES, MERCK ANIMAL HEALTH

2018-10-30 S 25,467 d 56,668 direct
Click here to report any possible errors with this stock listing.

Elevate your investments